Eric Allen Rose - 18 Mar 2026 Form 3 Insider Report for MESOBLAST LTD (MESO)

Role
Chief Medical Officer,Director, Director
Signature
/s/ Eric Allen Rose
Issuer symbol
MESO
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 09:34:32 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ROSE ERIC ALLEN Chief Medical Officer,Director, Director LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, AUSTRALIA /s/ Eric Allen Rose 18 Mar 2026 0002120513

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MESO Ordinary Shares 6,034,554 18 Mar 2026 Direct
holding MESO Ordinary Shares 714,720 18 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 33,333 $1.81 Direct
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 33,333 $1.81 Direct
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 33,334 $1.81 Direct
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 716,667 $1.01 Direct
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 406,922 $0.3600 Direct
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 406,922 $0.3600 Direct
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 406,921 $0.3600 Direct
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 148,000 $0.3500 Direct
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 716,667 $1.01 Direct
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 145,562 $0.9700 Direct
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 145,562 $0.9700 Direct
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 460,896 $0.9700 Direct
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 716,666 $1.01 Direct
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 592,000 $0.3500 Direct F2
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 630,666 $0.9700 Direct F3
holding MESO Option (right to buy) 18 Mar 2026 Ordinary Shares 820,000 $2.46 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such Ordinary Shares are represented by American Depositary Shares.
F2 Granted on October 16, 2023. Vesting is dependent on Mr. Rose achieving certain milestones.
F3 Granted on August 27, 2024. Vesting is dependent on Mr. Rose achieving certain milestones.
F4 Granted on August 26, 2025. Vesting is dependent on Mr. Rose achieving certain milestones.

Remarks:

1. All exercise prices are in Australian dollars.